The total return over the past 12 months is -83.74% vs. +16.94% for the S&P 500. So far it's up -73.80% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (83.74%) | (29.86%) | N/A | N/A | N/A | N/A |
| Total Return CAGR | (83.74%) | (29.86%) | N/A | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
NeuroSense Therapeutics Ltd. (NRSN)
| Year | Start price | End price | NRSN Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $15.38 | $4.03 | (73.80%) | +14.51% | (88.31%) |
| 2025 | $24.00 | $15.38 | (35.92%) | +17.72% | (53.64%) |
| 2024 | $15.70 | $24.00 | +52.87% | +24.89% | +27.98% |
| 2023 | $24.40 | $15.70 | (35.66%) | +26.19% | (61.85%) |
| 2022 | $49.20 | $24.40 | (50.41%) | (18.17%) | (32.24%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
